Physician profile
Jonathan David Ha
NPI 1740497098
$938.28
in general payments reported to CMS, 2019-2025
12 companies · $32.10 in 2025
The $32.10 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2020: $54.22 · 2021: $93.10 · 2022: $141 · 2023: $113 · 2024: $16.63 · 2025: $32.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $161.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $344.76 | 2019-2023 | Cook |
| Inari Medical, INC. | $129.86 | 2020-2022 | |
| Avenu Medical INC. | $122.77 | 2019 | |
| Abbvie INC. | $93.10 | 2021 | |
| Boston Scientific Corporation | $88.26 | 2019-2024 | Angiojet Ultra 5000a |
| Karl Storz Endoscopy-America | $42.96 | 2023 | |
| Bard Peripheral Vascular, INC. | $32.10 | 2025 | Peritx |
| Argon Medical Devices, INC. | $20.44 | 2019 | |
| Penumbra, INC. | $18.60 | 2020 | |
| Abbott Laboratories | $18.10 | 2023 | Jeti Peripheral Catheter |
| Medtronic USA, INC. | $13.81 | 2019 | |
| Medtronic, INC. | $13.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Ha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.